GLP-1 Was Only the Beginning: How Semaglutide, Tirzepatide and Retatrutide Moved Metabolic Research From One Target to Three
Not long ago, the modern metabolic-drug story could be explained with one receptor: GLP-1. That was complicated enough for most people. Then the science moved faster than the terminology. Semaglutide…
